PortfoliosLab logo
MMSI vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MMSI and LLY is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

MMSI vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merit Medical Systems, Inc. (MMSI) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

MMSI:

0.68

LLY:

-0.15

Sortino Ratio

MMSI:

1.20

LLY:

0.07

Omega Ratio

MMSI:

1.16

LLY:

1.01

Calmar Ratio

MMSI:

1.01

LLY:

-0.21

Martin Ratio

MMSI:

3.12

LLY:

-0.41

Ulcer Index

MMSI:

6.42%

LLY:

12.70%

Daily Std Dev

MMSI:

26.40%

LLY:

38.33%

Max Drawdown

MMSI:

-80.72%

LLY:

-68.27%

Current Drawdown

MMSI:

-12.04%

LLY:

-25.21%

Fundamentals

Market Cap

MMSI:

$5.77B

LLY:

$669.76B

EPS

MMSI:

$2.04

LLY:

$12.32

PE Ratio

MMSI:

47.85

LLY:

60.56

PEG Ratio

MMSI:

2.62

LLY:

1.10

PS Ratio

MMSI:

4.16

LLY:

13.67

PB Ratio

MMSI:

4.04

LLY:

41.83

Total Revenue (TTM)

MMSI:

$1.39B

LLY:

$49.00B

Gross Profit (TTM)

MMSI:

$662.85M

LLY:

$40.03B

EBITDA (TTM)

MMSI:

$304.59M

LLY:

$16.67B

Returns By Period

In the year-to-date period, MMSI achieves a 0.30% return, which is significantly higher than LLY's -7.15% return. Over the past 10 years, MMSI has underperformed LLY with an annualized return of 16.78%, while LLY has yielded a comparatively higher 27.99% annualized return.


MMSI

YTD

0.30%

1M

4.03%

6M

-4.59%

1Y

17.73%

5Y*

19.70%

10Y*

16.78%

LLY

YTD

-7.15%

1M

-5.14%

6M

-11.56%

1Y

-5.73%

5Y*

36.76%

10Y*

27.99%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MMSI vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MMSI
The Risk-Adjusted Performance Rank of MMSI is 7676
Overall Rank
The Sharpe Ratio Rank of MMSI is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of MMSI is 7171
Sortino Ratio Rank
The Omega Ratio Rank of MMSI is 7070
Omega Ratio Rank
The Calmar Ratio Rank of MMSI is 8484
Calmar Ratio Rank
The Martin Ratio Rank of MMSI is 7979
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 3939
Overall Rank
The Sharpe Ratio Rank of LLY is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 3838
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 3737
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 3737
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 4141
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MMSI vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Merit Medical Systems, Inc. (MMSI) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MMSI Sharpe Ratio is 0.68, which is higher than the LLY Sharpe Ratio of -0.15. The chart below compares the historical Sharpe Ratios of MMSI and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

MMSI vs. LLY - Dividend Comparison

MMSI has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.75%.


TTM20242023202220212020201920182017201620152014
MMSI
Merit Medical Systems, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.75%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%2.84%

Drawdowns

MMSI vs. LLY - Drawdown Comparison

The maximum MMSI drawdown since its inception was -80.72%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for MMSI and LLY. For additional features, visit the drawdowns tool.


Loading data...

Volatility

MMSI vs. LLY - Volatility Comparison

The current volatility for Merit Medical Systems, Inc. (MMSI) is 7.11%, while Eli Lilly and Company (LLY) has a volatility of 22.06%. This indicates that MMSI experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

MMSI vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Merit Medical Systems, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
355.35M
12.73B
(MMSI) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

MMSI vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Merit Medical Systems, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20212022202320242025
48.4%
82.5%
(MMSI) Gross Margin
(LLY) Gross Margin
MMSI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merit Medical Systems, Inc. reported a gross profit of 172.02M and revenue of 355.35M. Therefore, the gross margin over that period was 48.4%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

MMSI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merit Medical Systems, Inc. reported an operating income of 41.03M and revenue of 355.35M, resulting in an operating margin of 11.6%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

MMSI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merit Medical Systems, Inc. reported a net income of 30.15M and revenue of 355.35M, resulting in a net margin of 8.5%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.